Company profile for Replicate Bioscience

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Replicate Bioscience is amplifying the power of RNA therapeutics by pioneering novel self-replicating RNA (srRNA) technology. Replicate’s off-the-shelf srRNAs contain two components: virally derived genetic code to drive controlled and self-limiting amplification, and the RNA encoding therapeutic proteins. Our library of viral vectors, selected for driving robust and sustained protein expression and orders-of-magnitude impro...
Replicate Bioscience is amplifying the power of RNA therapeutics by pioneering novel self-replicating RNA (srRNA) technology. Replicate’s off-the-shelf srRNAs contain two components: virally derived genetic code to drive controlled and self-limiting amplification, and the RNA encoding therapeutic proteins. Our library of viral vectors, selected for driving robust and sustained protein expression and orders-of-magnitude improved performance over linear mRNA, allows for the development of treatments in applications including oncology, infectious disease, and autoimmunity.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
10210 Campus Point Dr, #150, San Diego, California 92121
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/replicate-bioscience-announces-publication-of-promising-new-phase-1-durability-data-for-its-srrna-vaccine-candidate-rbi-4000-302565754.html

PR NEWSWIRE
24 Sep 2025

https://www.fiercebiotech.com/biotech/novo-nordisk-seeks-obesity-refresh-550m-replicate-research-deal

FIERCE BIOTECH
29 Aug 2025

https://www.prnewswire.com/news-releases/replicate-bioscience-announces-publication-of-first-in-human-data-for-its-optimized-srrna-rabies-vaccine-in-nature-communications-302370692.html

PR NEWSWIRE
07 Feb 2025

https://www.prnewswire.com/news-releases/replicate-bioscience-presents-positive-data-from-phase-1-trial-and-preclinical-data-with-novel-self-replicating-rna-at-the-2024-american-society-of-gene--cell-therapy-asgct-annual-meeting-302142558.html

PR NEWSWIRE
11 May 2024

https://www.prnewswire.com/news-releases/replicate-bioscience-announces-oral-presentations-at-the-2024-american-society-of-gene--cell-therapy-asgct-annual-meeting-302123737.html

PR NEWSWIRE
22 Apr 2024

https://www.fiercebiotech.com/biotech/self-replicating-rna-rabies-vaccine-clears-early-test-boosting-replicates-plans-platform

FIERCE BIOTECH
14 Feb 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty